17 posts from April, 2011

Share Your Experiences with Euphytose

Posted April 26th, 2011 by

Available without a prescription in France, Euphytose is an herbal treatment for anxiety and depression that contains six plant extracts:  Hawthorn, Passionflower, Valerian, Ballota foetida, Cola nitida and Guarana (Paullinia cupana).  The latter is available in France as an over-the-counter anxiolytic (anti-anxiety) agent.

Producing both sedative and stimulant effects, Euphytose combines traditional herbal remedies for anxiety with components that are thought to act on central benzodiazepine receptors.  It had been studied in one short, double-blind, placebo-controlled trial involving 181 adults, with a statistically significant effect found for both reduction in symptoms and clinical response to Euphytose over placebo at the end of the trial.  In terms of safety, it was well-tolerated in the study with no difference in the number of adverse effects compared with placebo – and no serious adverse effects.

At PatientsLikeMe, where more than 125,000 patients are sharing their experiences with all types of treatments, two patients report trying Euphytose.   The reported purposes were “Anxious mood,” “Panic disorder” and “Insomnia.”  Effectiveness was rated as either “Moderate” or “Slight,” while side effects included “Drowsiness” and “Problems concentrating.”  Here’s what one patient with panic disorder wrote on his Euphytose treatment evaluationMakes you a little drowsy, but helps in limiting the effects of expected stressful situations.”

JOIN PATIENTSLIKEME TODAY

Have you taken Euphytose or another over-the-counter remedy for anxiety and depression?  Join PatientsLikeMe and add your experiences to our growing body of knowledge.  Then, stay to exchange advice and support, research common treatments and learn from other patients like you.

Join PatientsLikeMe


PatientsLikeMe Refutes Published Clinical Trial

Posted April 25th, 2011 by

screen-shot-2011-04-25-at-41612-pmCongratulations to our R&D team here at PatientsLikeMe for its most recent paper published in Nature Biotechnology (“Accelerated clinical discovery using self-reported patient data collected online and a patient-matching algorithm”).  The full paper has been made available by Nature so you can read the results and access all of the supplemental data and figures.

Below are links to some of the media coverage about the paper, as well as a link to our own news release announcing the study results.

A special thank you to all of the ALS patients on our site for sharing the data that helped create this new insight and accelerate discovery like its never been done before.  Now that we’re open to all patients with any condition, we know your sharing will inspire the masses to share and learn together.

***

Marketwire (our news release)
PatientsLikeMe Social Network Refutes Published Clinical Trial

The Wall Street Journal
ALS Study Shows Social Media’s Value as Research Tool
(paper)
The Future of Social Network-Based Trials
(blog)

Boston Business Journal
PatientsLikeMe hits ALS study

FierceBiotech IT
PatientsLikeMe study challenges prior ALS claims

PatientsLikeMe member bheywood